Biomarker
Multi-platform biomarker strategies from discovery through clinical development.
The most demanding programs rarely fit into a single modality. CellCarta’s expertise and capabilities are built to span tissue, gene, protein, and immune response without compromising quality or continuity.
Multi-platform biomarker strategies from discovery through clinical development.
Proven and emerging molecular platforms for clinical sample analysis and reporting.
Multiplexed tissue analysis with in-house pathologists and AI-powered image analysis.
Multiplex assays for immune response monitoring across the clinical trial continuum.
Validated immunoassay platforms for precise biomarker quantification and clinical testing.
Fully integrated MS platforms for large-scale discovery and bioanalytical testing.
We deliver what complex preclinical and clinical programs demand: depth, rigor, and consistency.
Deep Scientific Rigor
Integrated Multi-Modal Capabilities
Global Execution
Complex Biomarker Expertise
High-Touch Collaboration
